Literature DB >> 10411710

The course of the remnant kidney model in mice.

S Kren1, T H Hostetter.   

Abstract

The remnant kidney model was produced in mice by unilateral nephrectomy and partial infarction of the remaining kidney. Control mice underwent laparotomy only. The mice were studied for up to 44 weeks. No quantitative differences were noted in systolic arterial pressure, proteinuria, or histopathology between control mice and those with a remnant kidney. Glomerular enlargement occurred in the remnant kidney.

Entities:  

Mesh：

Year:  1999        PMID： 10411710     DOI： 10.1046/j.1523-1755.1999.00527.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  47 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Chronic nitric oxide deficiency and progression of kidney disease after renal mass reduction in the C57Bl6 mouse.

Authors:  Veronika Muller; You-Lin Tain; Byron Croker; Chris Baylis
Journal:  Am J Nephrol       Date:  2010-11-11       Impact factor: 3.754

3.  TGF-alpha mediates genetic susceptibility to chronic kidney disease.

Authors:  Denise Laouari; Martine Burtin; Aurélie Phelep; Carla Martino; Evangeline Pillebout; Xavier Montagutelli; Gérard Friedlander; Fabiola Terzi
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

4.  Impact of chronic kidney dysfunction on serum Sulfatides and its metabolic pathway in mice.

Authors:  Yosuke Yamada; Makoto Harada; Koji Hashimoto; Ran Guo; Takero Nakajima; Toshihide Kashihara; Mitsuhiko Yamada; Toshifumi Aoyama; Yuji Kamijo
Journal:  Glycoconj J       Date:  2018-12-10       Impact factor: 2.916

5.  Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.

Authors:  K A Nath; J P Grande; J J Haggard; A J Croatt; Z S Katusic; A Solovey; R P Hebbel
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  Increased expression of HIF-1alpha, VEGF-A and its receptors, MMP-2, TIMP-1, and ADAMTS-1 at the venous stenosis of arteriovenous fistula in a mouse model with renal insufficiency.

Authors:  Sanjay Misra; Uday Shergill; Binxia Yang; Rajiv Janardhanan; Khamal D Misra
Journal:  J Vasc Interv Radiol       Date:  2010-07-03       Impact factor: 3.464

7.  Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury.

Authors:  F Terzi; M Burtin; M Hekmati; P Federici; G Grimber; P Briand; G Friedlander
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

8.  JunD protects against chronic kidney disease by regulating paracrine mitogens.

Authors:  Evangéline Pillebout; Jonathan B Weitzman; Martine Burtin; Carla Martino; Pierre Federici; Moshe Yaniv; Gérard Friedlander; Fabiola Terzi
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis.

Authors:  Kuniko Kimura; Masayuki Iwano; Debra F Higgins; Yukinari Yamaguchi; Kimihiko Nakatani; Koji Harada; Atsushi Kubo; Yasuhiro Akai; Erinn B Rankin; Eric G Neilson; Volker H Haase; Yoshihiko Saito
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

10.  Effects of 5/6 nephrectomy on renal function and blood pressure in mice.

Authors:  Agata L Gava; Flavia Ps Freitas; Camille M Balarini; Elisardo C Vasquez; Silvana S Meyrelles
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.